QUR Medical ApS: Financial statements 2017
CVR: 29617783
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
QUR Medical ApS (CVR 29617783) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -6,430 and a net result of DKK -2,319 compared with DKK -8,742 the year before. Equity in the 2017 report amounted to DKK 90,459. The solvency ratio was 62.7%.
- Gross Profit
- DKK -6,430
- Profit/Loss
- DKK -2,319
- Equity
- DKK 90,459
- Total Assets
- DKK 144,244
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -6K | -2K | 90K | - |
| 2016 | - | -13K | -9K | 93K | - |
| 2015 | - | -5K | -882 | 102K | - |
| 2014 | - | -5K | -869 | 102K | - |
| 2013 | - | -5K | -1K | 103K | - |
Official annual report
Keep an eye on QUR Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout QUR Medical ApS
QUR Medical ApS is a Danish company of the type Anpartsselskab based in Havdrup, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK AF 30. MAJ 2006 ApS and TWL3 ApS. The management consists of Jens Steen Olsen. The company is owned by V-BIOTEK HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -438,885 and a net result of DKK -1,062,267 compared with DKK -714,429 the year before. Equity in the 2025 report amounted to DKK -5,831,392.